Overview

Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of a high fat meal and light meal on the blood levels of Daclatasvir, Asunaprevir and BMS-791325 after administration of the 3 drugs as a fixed-dose combination in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb